Entities affiliated with Steven A. Cohen
Beneficially own greater than 5% of our capital stock following the IPO
Purchased 1,025,000 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Alpha Wave Ventures II, LP
Beneficially owns greater than 5% of our capital stock; Chris Dimitropoulos, a former member of our Board, is a Managing Director of Alpha Wave Global LP
Purchased 600,000 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Entities affiliated with InVivium Capital
Michael Liang, Ph.D., a former member of our Board, is Managing Partner of InVivium Capital
Purchased 56,250 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz
Beneficiary is the spouse of Adam Savitz, our Chief Medical Officer
Purchased 17,000 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Robert L. Friedman 2003 Long-Term Trust fbo Andrew Friedman
Beneficiary is the brother-in-law of Adam Savitz, our Chief Medical Officer
Purchased 17,000 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Purchased 3,125 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Dan Segal
Beneficially owned greater than 5% of our capital stock prior to the IPO closing; previously served as a member of our Board
Purchased 1,563 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Purchased 1,563 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Oran Etkin
Sibling of Amit Etkin, M.D., Ph.D., our President, Chief Executive Officer and Chair of our Board
Purchased 938 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Alison Savitz & David Glass
Alison Savitz is the sibling of Adam Savitz, our Chief Medical Officer
Purchased 625 shares of common stock in the IPO directed share program at $16.00 per share
With underwriters
Open in proxy
Entities associated with Perceptive Advisors
Beneficial owner of greater than 5% of our capital stock
Purchased 2,536,354 shares issuable upon exercise of Pre-Funded Warrants in the 2025 private placement
With the Company
Open in proxy
Commodore Capital Master LP
Beneficial owner of greater than 5% of our capital stock
Purchased 1,000,000 shares of common stock and 1,536,354 shares issuable upon exercise of Pre-Funded Warrants in the 2025 private placement
With the Company
Open in proxy
Entities associated with Vestal Point Capital, LP
Beneficial owner of greater than 5% of our capital stock
Purchased 1,606,358 shares of common stock in the 2025 private placement
With the Company
Open in proxy
Entities associated with Point72 Asset Management
Beneficial owner of greater than 5% of our capital stock
Purchased 549,544 shares of common stock and 549,543 shares issuable upon exercise of Pre-Funded Warrants in the 2025 private placement
With the Company
Open in proxy
